CT041
- Generic Name
- CT041
- Drug Type
- Biotech
Overview
CT041 is an autologous CAR T-cell product candidate against protein Claudin18.2 (CLDN18.2).
Background
CT041 is an autologous CAR T-cell product candidate against protein Claudin18.2 (CLDN18.2).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath